Noam Solomon

Viola Ventures Ltd. (Viola Ventures) is a venture capital subsidiary of Viola Group founded in 2000 by Dovrat Group, Aharon Dovrat , Shlomo Dovrat, Harel Beit-On and Avi Zeevi. The firm is headquartered in Herzliya, Israel.

Microsonic Systems, Inc. develops acoustics-based instruments for biotech and pharmaceutical industries. It offers ultrasonic fluid processing devices including Microsonics ST30, a personal deoxyribonucleic acid sample preparations system; and HENDRIX SM100, a ultrasonic fluid processor. The company was founded by Steven Horwitz on August 24, 2004 and is headquartered in San Jose, CA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

Wing Venture Management LLC (Wing Venture Partners) is a venture capital firm founded in 2013 by Gaurav Garg and Peter Wagner. The firm is headquartered in Palo Alto, California.

Genome Compiler Israel Ltd. develops software for personalized synthetic genome design. It provides an intuitive all-in-one software platform for genetic engineers, molecular and synthetic biologists. The company was founded by Omri Amirav-Drory Nir Ben Moshe, Yogev Debbi and Roy Nevo in 2011 and is headquartered in Tel Aviv, Israel.

Seebo Interactive Ltd. provides end-to-end Internet of Things platform. Its Internet-of-Things development, production and runtime platform allows any product team to bring smart product ideas to mass market. The company was founded by Lior Akavia and Liran Akavia in 2012 and is headquartered in Tel Aviv, Israel.

LifeBEAM Technologies Ltd. manufactures wearable instruments for measuring human performances. Its products include helmets and hats, bio-sensors for motion-intensive activities to help pilots, special forces personnel. The company was founded by Zvika Orron and Omri Yoffe in 2011 and is headquartered in Tel Aviv, Israel.

NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California.

A.A.A Taranis Visual Ltd. provides solutions for farmers that allow the user to mitigate and respond to weather and crop disease threats. It offers solution to farmers to plan the field operations; analyze the planned tasks, field level weather forecast, and monitor conditions in the field. The company was founded by Ofir Schlam, Ayal Karmi, Asaf Horvitz and Eli Bukchin in 2015 and is headquartered in Tel Aviv, Israel.

Metabiotech Corp. operates a platform technology for reading and fixing DNA. Its synthetic biology solutions accelerate the design-build-test cycle for biotechnology and bioengineering and genomics pipeline that discovers clinically actionable genetic information for human diseases. The company was founded by Tuval Ben-Yehezkel and is headquartered in San Jose, CA.

Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA.

VI Technologies, Inc. manufactures wearable instruments for measuring human performances. It offers Vi ear buds. The company was founded by Omri Yoffe and is headquartered in New York, NY.

xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.

Pliops Ltd. enables cloud and enterprise data centers to access data up to 50X faster with 1/10th of the computational load and power consumption. Its technology collapses multiple inefficient layers into one ultra-fast device based on a groundbreaking patent-pending approach. The company was founded by Uri Beitler, Moshe Twitto and ARYESH Mergi in 2017 and is headquartered in Ramat Gan, Israel.

ProteanTecs Ltd. develops software for electronics industry. It specializes in chip design, machine learning, and analytics software. The company was founded by Roni Ashuri, Shai Cohen, and Evelyn Landman and is headquartered in Haifa, Israel.

Omri AD Tech.Bio Ltd. was founded by Omri Amirav-Drory on September 17, 2019 and is headquartered in Herzliya, Israel.

NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA.

Cellsonics, Inc. engages in development of a next generation single cell isolation. The company is headquartered in Newark, DE.

C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY.

DataGen Technologies Ltd. engages in the provision of solutions to train neural networks to understand semantic objects captured in real-world images and three-dimensional scans. The company was founded by Ofir Chakon and Gil Elbaz in 2018 and is headquartered in Tel Aviv, Israel.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Light Bio, Inc. engages in other technology industry. The company is headquartered in Mount Horeb, WI.

Wild Biotech Ltd. develops a drug discovery platform. The private company is based in Rehovot, Israel. The Israeli company was founded by Ido Bachelet, Neta Raab, and Doron Levin. The CEO is Neta Raab.

Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation.

Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker.

Talus Bioscience, Inc. is a company that aims to address the primary cause of cancer and other diseases, which is regulome dysfunction. The company is based in Seattle, WA, and recently raised 9.75 million in seed funding to support their efforts. The company is focused on developing a drug discovery platform that can rapidly measure and manipulate the regulome, providing a new approach to cancer therapeutics. The company has also hired a new COO, Michelle Briscoe. Talus Bioscience was founded by Alex Federation and Lindsay Pino, with Alex Federation serving as CEO since incorporation.

4M Analytics Ltd. is an Israeli company that aims to create the first digitized, accurate, and up-to-date map of buried utilities. The company is based in Herzliya, Israel and was founded in 2019. The company's unique technology provides a subsurface utility map with a complete and accurate subsurface-infrastructure database. Itzik Malka has been the CEO of the company since 2019.

Speedata Ltd. is an Israeli company that was founded in 2019 with the aim of disrupting analytics and database processing in data centers. The company is based in Netanya, Israel. The company has developed a new, scalable, massively parallel architecture that is software compatible with existing ecosystems and optimized for big data and analytics workloads. The company's analytics processing unit (APU) is designed to optimize big data and analytics workloads. Speedata provides complete hardware and software solutions, with cutting-edge chip architecture to optimize performance efficiency and scale, providing seamless migration for a wide variety of software frameworks. The company was founded by Rafi Shalom, Itai Incze, Yoav Etsion, Dani Voitsechov, Dan Charash, Jonathan Friedmann. Jonathan Friedmann has been the CEO since incorporation.

Pepper Bio, Inc. develops an AI-based drug discovery platform. The American company was founded by Samantha Dale Strasser and Yu Jon Hu, with Yu Jon Hu serving as the CEO since incorporation.

Gilboa Therapeutics Ltd. is a preclinical-stage biopharmaceutical company located in Israel. The Israeli company is focused on developing novel and high-impact, next-generation cancer immunotherapies that harness the power of a patient's own immune system to treat cancer, improve outcomes, and save lives. Gilboa's proprietary technology, solidt, is an engineered cell therapy that targets multiple different tumor types and is intended to be used in combination with a wide range of antigen-specific antibodies. The company is driven by a sense of urgency to discover, develop, and rapidly bring their game-changing new therapeutics to cancer patients in need, significantly improving outcomes and saving lives.

Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation.

La Jolla Labs, Inc. is a company that utilizes RNA biology, automation, cloud computing, and machine learning to provide innovative medical solutions to patients. The company is based in La Jolla, CA. The company specializes in various RNA-targeting modalities, such as splicing gapmers, miRNA, antisense oligonucleotides, and siRNA. The CEO of the company is Donald Jeff Milton.

Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation.

Mana.Bio operates as an AI based drug delivery company. The company was founded by Yogev Debbi and Roy Nevo and is headquartered in United States.

ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation.

Cancer Commons is a non-profit organization that provides compassionate support for people with advanced or metastatic cancer. The private company is based in Palo Alto. The American company's services include leading-edge care navigation and personalized action plan creation for people with advanced or metastatic cancer. Founded in 2012, the company works one-on-one with patients and caregivers to surface the best-possible action plan for anyone dealing with advanced cancer.